No takes yet. Share an insight, caveat, or question.
Randomized trial demonstrates UNC93B1 variants lead to heightened TLR7 signaling in SLE, suggesting new treatment avenues.
Wolf et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: